Xuanzhu Biological Port's IPO and domestically unlisted shares "full circulation" have been filed with the China Securities Regulatory Commission.

The International Cooperation Department of the China Securities Regulatory Commission issued a filing notice for the overseas issuance and listing of Xuanzhu Biology Technology Co., Ltd. and the "full circulation" of domestically unlisted shares. The company plans to issue no more than 77,433,500 shares of overseas listed common stock and list on the Hong Kong Stock Exchange. 17 shareholders of the company plan to convert a total of 93,368,496 domestically unlisted shares into overseas listed shares, which will be traded on the Hong Kong Stock Exchange.